570 — China Traditional Chinese Medicine Holdings Co Balance Sheet
0.000.00%
- HK$10.17bn
- HK$11.67bn
- CNY16.51bn
- 40
- 45
- 21
- 25
Annual balance sheet for China Traditional Chinese Medicine Holdings Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | HKAS | HKAS | HKAS | HKAS | — |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 5,027 | 4,141 | 3,670 | 3,904 | 5,336 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 5,033 | 8,794 | 7,992 | 9,553 | 8,567 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 15,132 | 18,203 | 17,967 | 19,800 | 18,840 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 7,470 | 7,866 | 7,924 | 7,960 | 7,714 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 33,088 | 36,389 | 35,637 | 37,068 | 35,064 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 7,535 | 8,765 | 10,103 | 9,333 | 7,800 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 15,024 | 16,671 | 15,469 | 15,908 | 13,860 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 18,064 | 19,719 | 20,168 | 21,160 | 21,204 |
Total Liabilities & Shareholders' Equity | 33,088 | 36,389 | 35,637 | 37,068 | 35,064 |
Total Common Shares Outstanding |